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CELLULAR NEUROSCIENCE

Uncontrolled mitochondrial calcium uptake underlies
the pathogenesis of neurodegeneration in
MICU1-deficient mice and patients
Raghavendra Singh1†, Adam Bartok1,2†, Melanie Paillard1, Ashley Tyburski3,
Melanie Elliott3, György Hajnóczky1*

INTRODUCTION

2+

Mitochondrial metabolism, redox, and Ca homeostasis are cen
tral to orchestrating neuronal function in health (1), and their im
pairments are linked to neurodegenerative diseases (amyotrophic lateral
sclerosis, Alzheimer’s disease, Parkinson’s disease, and Huntington’s
disease) (2–11). In the past years, numerous patients with neuro
muscular and cognitive impairments have been identified with the
loss-of-function mutation of MICU1 (12–16), the Ca2+ sensing reg
ulator of the mitochondrial calcium uniporter complex (mtCU),
which is the main pathway for mitochondrial Ca2+ entry (17–20).
These studies suggest a direct link between the patients’ symptoms
and the altered mitochondrial calcium signaling, which might be also
relevant for the common neurodegenerative diseases; however, thus
far, no evaluation in a neuronal model has been performed.
Neurons developed complex Ca2+ signaling pathways that are
engaged in the control of cellular metabolism, cell survival, gene expres
sion, and membrane excitability. To induce a cytoplasmic [Ca2+]
([Ca2+]c) rise, Ca2+ enters neurons mainly through voltage-gated or
ligand-activated Ca2+ channels (21), and mobilized from the endo
plasmic reticulum Ca2+ store (22). Mitochondria take up Ca2+
during the [Ca2+]c signals and subsequently release Ca2+ back to the
cytoplasm. Although only a relatively small fraction of Ca2+ are
handled by mitochondria during physiological [Ca2+]c signals, be
cause of their strategic positioning, mitochondrial Ca2+ influx and
efflux play a role in the spatiotemporal organization of the [Ca2+]c
signals (1). Mitochondrial Ca2+ uptake also results in a rise in mito
chondrial matrix [Ca2+] ([Ca2+]m) that stimulates oxidative ATP pro
duction and other intramitochondrial targets (23). Thus, neurons need
a powerful mitochondrial Ca2+ transport mechanism under tight control.
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Ca2+ is accumulated in the mitochondria via a Ca2+-selective ion
channel, mtCU, located in the inner mitochondrial membrane. mtCU
is a hetero-oligomeric channel complex composed of the pore-forming
protein, MCU (24, 25); an essential scaffold, essential MCU regulator
(EMRE) (26); and Ca2+-sensitive regulators, MICU1 (27), MICU2
(28), and MICU3 (29). Loss of MCU or EMRE prevents mitochondrial
Ca2+ uptake. In addition to supporting pore formation by tetrameric
MCU, EMRE anchors MICU1 to MCU (30). However, MICU1 also
binds directly to the DIME motif of the MCU tetramer (31). On the
basis of recent structural data, the mtCU complex has 4:4:1:1 stoi
chiometry of MCU, EMRE, MICU1, and MICU2 (32). A dimer of
MICU proteins appears to determine both the threshold and coop
erative activation of the mtCU by Ca2+, thus providing a mechanism
for the supralinear [Ca2+]c activation of the mtCU (20, 33). The MICU
proteins have EF-hand Ca2+-binding domains (32, 33) localized to
the intermembrane space (20, 34), making them suitable to sense
[Ca2+]c signals for the control of mitochondrial Ca2+ uptake. In
practical terms, Ca2+-free MICUs support closure of the mtCU pore
and suppresses mitochondrial Ca2+ uptake, whereas the Ca2+-bound
MICUs promote the Ca2+ flux. Because MICU2 has lower and MICU3
has higher affinity for Ca 2+ than MICU1, the MICU1-MICU2
dimer elevates, whereas the MICU1-MICU3 dimer lowers the [Ca2+]c
threshold for mtCU opening (29, 33, 35). Evidence supports that
MICU1 and MICU2 are broadly expressed (28, 36), whereas MICU3
is mostly expressed in the brain (34), but the effect of age or neuro
degeneration on their abundance remains elusive.
Ca2+ uptake is balanced by Ca2+ efflux mediated by Ca2+ ex
changers, like NCLX, an Na+-dependent exchanger with relevance
in the brain (37, 38), and by a large conductance channel, the per
meability transition pore (PTP), that commonly opens under mito
chondrial Ca2+ overload conditions, including excitotoxic injury in
neurons (39).
Loss of MCU in mice does not cause neurological defects but
causes skeletal muscle (SM) dysfunction during strenuous work
(40). We have shown that lack of MICU1 in SM alters the cellular
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Downloaded from https://www.science.org at Thomas Jefferson University on April 05, 2022

Dysregulation of mitochondrial Ca2+ homeostasis has been linked to neurodegenerative diseases. Mitochondrial
Ca2+ uptake is mediated via the calcium uniporter complex that is primarily regulated by MICU1, a Ca2+-sensing
gatekeeper. Recently, human patients with MICU1 loss-of-function mutations were diagnosed with neuromuscular
and cognitive impairments. While studies in patient-derived cells revealed altered mitochondrial calcium signaling,
the neuronal pathogenesis was difficult to study. To fill this void, we created a neuron-specific MICU1-KO mouse
model. These animals show progressive, abnormal motor and cognitive phenotypes likely caused by the degeneration of motor neurons in the spinal cord and the cortex. We found increased susceptibility to mitochondrial
Ca2+ overload-induced excitotoxic insults and cell death in MICU1-KO neurons and MICU1-deficient patientderived cells, which can be blunted by inhibiting the mitochondrial permeability transition pore. Thus, our study
identifies altered neuronal mitochondrial Ca2+ homeostasis as causative in the clinical symptoms of MICU1deficient patients and highlights potential therapeutic targets.
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Ca2+ homeostasis during myofiber contraction and leads to muscle
atrophy, SM weakness, fatigue, and weakened repair of the dam
aged sarcolemma (41). However, the role of MICU1 regulation of
mtCU Ca2+ uptake in the development of neuronal phenotype like
learning disability and motor dysfunction is still enigmatic. Here,
we introduce a novel neuronal MICU1–knockout (KO) mouse
(nKO) model to study the role of the mtCU gating by Ca2+ in neu
ronal biology and in the neurological impairments of patients. The
nKO shows progressive, abnormal motoric and cognitive pheno
type and degeneration of motor neurons in the spinal cord and the
cortex. We found lower Ca2+ uptake threshold and maximal capac
ity in isolated cortical mitochondria increased susceptibility to mi
tochondrial Ca2+ overload and cell death in primary, cultured KO
neurons, similarly to fibroblasts and lymphoblast of a human
MICU1-deficient patient. Our study identifies the common caus
ative of the clinical symptoms of the MICU1-deficient patients and
the phenotype of the MICU1-KO mice at the level of neuronal mi
tochondrial Ca2+ homeostasis.

RESULTS

Eno2-Cre knocked down MICU1 after birth
To establish a neuron-specific MICU1-KO (nKO) mouse model, we
used MICU1-floxed mice (42) and the Eno2-Cre-loxP system (43, 44)
to target exon 3 of the MICU1 gene in neurons. nKO animals bred
and developed normally, with no signs of impairments in the colony.
Littermate MICU1-floxed [wild-type (WT)] animals were housed
together with nKO animals and used as control in the experiments.
To validate the KO of MICU1, we isolated mitochondria from the
brain cortex in different age groups and immunoblotted for pro
teins involved in mitochondrial Ca2+ homeostasis (Fig. 1, A and B,
and fig. S1A). From as early as 3 weeks of age, MICU1 protein was
significantly decreased in nKO animals, although a remaining amount,
likely derived from glial mitochondria in the prepared sample (45),
was present in nKO animals. Decrease in MICU1 abundance was
associated with reduced MICU3 and EMRE protein levels in all
postnatal age groups, and in MICU2 and MCU at 9 to 12 months of
age. EMRE decrease, a possible adaptive mechanism, has been also
Downloaded from https://www.science.org at Thomas Jefferson University on April 05, 2022

Fig. 1. Progressive cognitive and motor impairments in neuronal MICU1-KO mice. (A) Immunoblot image of proteins involved in mitochondrial Ca2+ homeostasis in
isolated cortical mitochondria of 3-month-old mice. HSP70 was used as loading control. (B) Protein levels relative to HSP70, normalized to those in WT, in cortical mitochondria from different age groups (N = 5 to 8 animals per condition). (C) Protein levels in embryonic cortical lysates (N = 7 pairs). (D) mRNA levels in the cortex determined with qPCR on cDNA transcript of isolated mRNA and normalized to the levels measured in WT (N = 6 pairs). (E) Three- and 9-month-old animals tested on Barnes
maze. Latency [depicts the time (seconds) taken by animals to find the escape box), distance (total distance traveled between the starting point and the escape box
during the trial), path efficiency (0-1, where 1 is a straight line between the starting point and the escape box), and average speed are shown, three trials on four
consecutive testing days (N = 8 to 9 pairs each age]. (F) Grip strength measured with wire-hanging test. Latencies to fall in different age groups of nKO and smKO mice
(N = 4 to 9 animals per group). (G) Rotarod test applying linear acceleration. Maximal duration times before falling in different age groups of nKO and smKO mice
(N = 4 to 9 animals per group). (H) Scores on the pole test in 3- and 9-month-old animals (N = 8 to 14 animals per group). (E to H) In each age group, naïve animals
were tested. ns, not significant; P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001.
Singh et al., Sci. Adv. 8, eabj4716 (2022)
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observed in other model systems (41, 42, 46). By contrast, in embryon
ic day 16 (E16; 16th day of gestation) cortical lysates, we found no
changes in the levels of MICU1, MCU, or EMRE proteins (Fig. 1C
and fig. S1A). This is consistent with the expression of Cre initiating
after birth and thus the presence of MICU1 during embryonic
development, which likely explains the viability of the colony as
opposed to the whole-body MICU1-KO (KO) (42). In terms of gene
expression in the brain cortex of adult nKO animals, we found
decreased mRNA levels of MICU1 and EMRE, but not of MICU3
(Fig. 1D). To test whether any perturbations of the mtCU complex
subunits occurred beyond the nervous system in the nKO mice, we
performed immunoblots of mitochondria isolated from the SM. No
difference among the age-matched (15 to 18 months) nKO and WT
animals was detected (Fig. 1B). This suggests that Eno2-Cre–mediated
MICU1-KO is specific to neurons.

Spinal cord motoneuron loss and cortical dendritic spine
morphology alterations in nKO mice
Because a set of behavioral tests (grip test, rotarod, and pole test)
performed on adult male and female nKO animals (fig. S1B) show a
similar trend in all tests points, we randomly chose males to carry
out further experiments. To understand the pathological basis of the
motor disabilities in nKO animals, we examined the motor neurons
in the spinal cord anterior horn in aged animals (15 to 19 months,
Singh et al., Sci. Adv. 8, eabj4716 (2022)
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Altered excitability and mitochondrial Ca2+ signaling in KO
primary mouse neurons
Because in the nKO, MICU1 is knocked out only after birth, to fur
ther investigate the consequences of MICU1 loss in neuronal Ca2+
homeostasis, we used primary embryonic cortical neuronal cultures
from the whole-body MICU1-KO (KO) mouse model (42). In the
complete absence of MICU1 expression (Fig. 3, A and B), we found
decreased abundance of MICU3 and EMRE proteins like in the
3-week-old or older nKO (Fig. 3A). In the embryonic neurons,
MICU3 and EMRE both showed decreased mRNA levels (Fig. 3B).
We first stimulated the primary neurons with simultaneous ad
dition of a -aminobutyric acid (GABA) receptor antagonist, Bicu
culline (Bicu), and a K+ channel inhibitor, 4-aminopyridine (4AP),
to produce intracellular Ca2+ spiking via activation of the synaptic
N-methyl-d-aspartate (NMDA) receptors (55–57). We measured
[Ca2+]c with fura2 and found that ~63% of MICU1-KO neurons did not
display a [Ca2+]c spike upon Bicu + 4AP exposure as compared with
WT neurons where ~9% of neurons were nonresponsive (Fig. 3C).
The difference in excitability might reflect altered synaptic activity
in KO neurons. A recent study showed that the deletion of NCLX
caused decreased synaptic activity and plasticity in neuronal mito
chondria (58). When we included in our analysis only those neurons
that were responsive to Bicu + 4AP, we found that [Ca2+]c rise was
not significantly attenuated in KO as compared with WT neurons
3 of 13
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Progressive demise in learning and motor ability in nKO mice
Having a viable nKO mouse model gave us an opportunity to ex
plore the effect of neuronal loss of MICU1 on cognitive and motor
behavior of animals. To start probing cognitive impairments, spa
tial learning was tested with a Barnes maze (47) in young (3 months,
male) and older (9 months, male) animals (Fig. 1E). At 3 months of
age, only minor differences were observed for all parameters tested
between WT and nKO animals during the four trial days. Differently,
at 9 months, latency to find the target/scape box and distance trav
eled were greatly increased in the nKO, suggesting that the learning
ability of the nKO lagged behind that of the WT animals. The aver
age speed, a measure of the basic locomotor functions, did not show
differences at any age between nKO and WT animals. We next
studied the motor behavior of animals from different ages groups
(3, 9, and 12 to 20 months). The grip test (Fig. 1F) and the rotarod
test (Fig. 1G) (48) both showed age-dependent, progressive decreases
in performance for nKO animals. In comparison, SM-specific MICU1-
KO (smKO) (41) animals did not show a significant decrease in per
formance in the grip and rotarod tests (Fig. 1, F and G). With the
pole test, we did not find any significant difference at the age of
3 months, in contrast, although at 9 months, we observed that ~30%
of the MICU1-nKO could not perform the task (Fig. 1H). Notably,
the above-described pole, grip, and rotarod results were obtained with
male mice, but we also performed similar studies on a small cohort
of female mice, in which the nKO showed a clear trend in all tests to
a similar phenotype to what we observed in male animals (fig. S1C).
Body weight and muscle fiber morphology did not indicate SM at
rophy in nKO animals that might be due to unaltered MICU1 pro
tein levels in SM (fig. S1, B and D). Thus, our results link neuronal
MICU1 to both learning and motor functions and support neuron-
specific MICU1 loss as the dominant factor in the progressive motor
dysfunction in patients with MICU1 mutations. Moreover, the pro
gressive behavioral defects due to MICU1 absence, as in human
patients, affect both genders in nKO mice.

Nissl staining). We found reduced Nissl-positive neuronal counts
and a high percentage of the neurons with vacuolization in the nKO
animals (Fig. 2A). Motor neuron-specific staining [choline acetyl
transferase (ChAT)] confirmed decreased motor neuron counts
(Fig. 2B), which were coupled with overexpression of glial fibrillary
acidic protein (GFAP), a marker of reactive gliosis in the spinal cord
of nKO animals (Fig. 2C), confirming lower motor neuron degen
eration (49, 50) in the absence of MICU1.
Mitochondrial requirement in dendritic spine morphogenesis
(51) and spine pathology in motor (52) and cognitive dysfunction
(53) led us to examine the barbarization of neuronal dendrites in
the prefrontal cortex of animals in different age groups (3, 9, and 18
to 19 months) (Fig. 2, D to G). We found abnormal dendritic spines
characterized by decreased number, shorter length, and smaller head
area and diameter in nKO animals that progressed with age (Fig. 2F).
Although some of the abnormal phenotypes (head area and diameter)
are already present at 3 months, we could not observe significant
differences with detailed morphological analysis of the dendritic
spines (Fig. 2G). However, in aged animals (18 to 19 months), we
found higher proportion of premature (thin or filopodia) and lower
proportion of mature (mushroom) states in nKO animals (Fig. 2H),
which further confirms the progressive nature of the neuronal phe
notype. Degeneration of motor neurons in the spinal cord and al
tered dendritic arborization in the prefrontal cortex of nKO animals
could be the cause of the motor defects.
To connect the in vivo animal and brain structure phenotype to
Ca2+ homeostasis, first we isolated mitochondria from the cortex of
aged nKO animals and evaluated their Ca2+ clearance. nKO brain
mitochondria showed reduced Ca2+ uptake at high cytoplasmic [Ca2+]
([Ca2+]c), ~20 M (Fig. 2, H and I), and increased use of total Ca2+
uptake capacity at submicromolar [Ca2+]c (fig. S2, A to C) than agematched WT. This replicates the previously described lower [Ca2+]c
threshold and decreased maximal Ca2+ flux in MICU1-deficient
mitochondria (20, 33, 46, 54).
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(Fig. 3, D and E). As reported by others (29), the responsive cells
showed [Ca2+]c oscillation, without a change in the mitochondrial
membrane potential (m) measured by tetramethylrhodamine
methyl ester (TMRM) (fig. S3, A to D).
To also study the mitochondrial Ca2+ homeostasis, we simulta
neously measured [Ca2+]c with fura2 and mitochondrial matrix
[Ca2+] ([Ca2+]m) using a mitochondrial matrix–targeted calcium
sensor, mito-GCaMP6f (Fig. 3, F and G). Difference images created
by subtracting the prestimulation mito-GCaMP6f image from the
ones obtained at 1 and 2 s of Bicu + 4AP stimulation showed an
early rise in mito-GCaMP6f intensity in KO neurons (Fig. 3F). Sim
ilarly, the line graph also showed an early rise of [Ca2+]m in the KO
neurons (Fig. 3G, right). Furthermore, the delay of the half-maximal
[Ca2+]m signal relative to the half-maximal [Ca2+]c rise was shorter
in the KO as compared with WT (Fig. 3H).
Because the Bicu + 4AP–induced [Ca2+]c oscillations are hetero
geneous among the neurons, we next evoked action potentials using
pulse field electric stimulation (PFES) to induce intracellular Ca2+
influx in the presence of NMDA (MK801) and AMPA (GYKI
52466) receptor inhibitors. Thus, we bypassed the neurotransmitter-
dependent activation pathways and relied on voltage-gated ion
Singh et al., Sci. Adv. 8, eabj4716 (2022)
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channels to initiate neuronal Ca2+ responses. While the PFES-
induced [Ca2+]c rise was similar in both WT and KO neurons
(Fig. 4A, left), the [Ca2+]m rose earlier in KO neurons as compared
with WT (Fig. 4, A, right, and B). The closer [Ca2+]c-[Ca2+]m cou
pling during both Bicu + 4AP and electrical stimulations likely
results from the absence of the gatekeeping function of MICU1 on
MCU (20, 59, 60) in the KO neurons. To further test this, we quan
tified the resting [Ca2+]m levels using a ratio metric genetic sensor,
mtGEM-GECO, and observed higher resting [Ca2+]m in MICU1KO neurons as compared with WT (Fig. 4C). Along this line, dis
charging the basal mitochondrial calcium content by an uncoupler
(FCCP and oligomycin) caused a greater [Ca2+]c rise in KO than in
WT neurons (Fig. 4, D and E), further supporting the lack of effec
tive gatekeeping in MICU1-KO neurons.
Vulnerability to glutamate-induced delayed Ca2+
dysregulation and cell death in KO neurons
We have previously shown that MICU1-deficient mitochondria are
prone to mitochondrial Ca2+ overload and cell death in cell lines and
hepatocytes (42). Others have reported that overexpression of MCU
leads to neuronal death (61). These findings led us to hypothesize
4 of 13
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Fig. 2. Motor neuron degeneration in the spinal cord and altered dendritic spine morphology in the cortex of nKO mice. (A) Coronal sections of the spinal cord
visualized by Nissl staining (scale bars, 200 m). Neuron numbers determined in the anterior horn (red) (bottom left, N = 20 WT and 29 nKO sections from three WT and four
nKO animals, 15 to 19 months). Neuronal morphology shown by the percentage of vacuolated cells (red arrows) (bottom right, N = 13 WT and 22 nKO slides). (B) Motor
neurons visualized by immunofluorescent ChAT staining (top, white arrows; scale bar, 100 m). Motor neuron numbers (bottom, N = 12 sections per condition). AFU,
arbitrary fluorescence unit. (C) Gliosis shown by GFAP staining (top; scale bars, 200 m) and measured as the mean fluorescence intensity (bottom, N = 10 sections from
five animals per condition). (D) Pyramidal neurons in the prefrontal cortex in different age groups visualized by Golgi staining (samples from 18-month-old animals are shown;
scale bar, 50 m). (E) Dendritic spine morphology in 18-month-old WT and nKO animals (scale bar, 5 m). (F) Dendritic spine density (top left), spine length (top right),
spine head area (bottom left), and spine head diameter (bottom right) (N = 3 to 4 animals per group). (G) Classification of spine head morphology in 3-month-old (top)
and 18-month-old (bottom) animals. (H) Clearance of a Ca2+ bolus (arrow, 50 M CaCl2), measured in cortical mitochondria in the presence or absence of Ru265 (5 M).
(I) Mitochondrial Ca2+ uptake per milligram of protein (N = 5 runs per condition, 12 to 15 months). ns, not significant; P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001.
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Fig. 3. Altered neuronal excitability and mitochondrial Ca2+ signaling in MICU1-KO neurons upon Bicuculline (Bicu) and 4-aminopyridine exposure (4AP).
(A) Immunoblot images of proteins involved in mitochondrial Ca2+ uptake in WT and full-body MICU1-KO embryonic cortices (E16) (left). Protein levels relative to loading
control HSP70 were normalized to those in WT (right, N = 5 WT and 3 KO). (B) mRNA levels determined with RT-PCR (top) and qPCR (bar graph) on cDNA transcript of
embryonic cortical mRNA and normalized to the levels measured in WT (N = 4 to 13 per condition). (C) Percentage unresponsive neurons to Bicu (10 M) and 4AP (100 M)
(Bicu + 4AP) (where [Ca2+]c rise was not seen or seen >1 min after stimulation) (six independent experiments). (D) Mean [Ca2+]c traces measured with fura2 upon Bicu +
4AP stimulation (N = 26 WT, 34 KO runs). (E) Bicu + 4AP–induced maximum [Ca2+]c rise [calculated from the individual traces of (C)]. (F) Representative difference images
(scale bar, 20 m) of neurons showing [Ca2+]c and [Ca2+]m rise upon Bicu + 4AP stimulation. The images were created by subtracting mtGCaMP6f and fura2 image obtained at 1 and 2 s after Bicu + 4AP stimulation from the respective reference image acquired 1 s before stimulation. (G) Mean [Ca2+]c (left) and [Ca2+]m (right) traces in
primary cortical neurons upon Bicu + 4AP stimulation. (H) Coupling time between [Ca2+]c and [Ca2+]m rise (calculated as time to [Ca2+]m ½ max rise − time to [Ca2+]c ½ max
rise, N = 30 WT, 37 KO runs). ns, not significant; P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
Singh et al., Sci. Adv. 8, eabj4716 (2022)

18 March 2022
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that loss of neurons in nKO mice might be caused by [Ca2+]m
overload–induced cell death. To test this possibility, we first measured
the initial [Ca2+]c and [Ca2+]m signals simultaneously upon excito
toxic glutamate challenge (fig. S3, E and F). The [Ca2+]c signals did
not differ in WT and KO neurons (fig. S3, E, G, and J to L). Howev
er, similarly to Bicu + 4AP and electrical stimulation, we found that
the [Ca2+]m rise initiated earlier (fig. S3, F, H, and M) and was more
closely coupled to the [Ca2+]c rise (fig. S3I) in the absence of MICU1.
To check whether the glutamate challenge caused delayed [Ca2+]c
dysregulation (DCD), we monitored [Ca2+]c simultaneously with the
m for longer periods of time (Fig. 5, A to G). The glutamate-
induced initial [Ca2+]c rise was followed by a progressive secondary phase
of [Ca2+]c increase and was coupled with mitochondrial depolarization
in both genotypes. However, the secondary phase of the [Ca2+]c rise
and associated m loss were evident earlier and larger in MICU1KO neurons (Fig. 5, E to G). Moreover, the uncoupler-induced mito
chondrial depolarization caused a smaller additional [Ca2+]c rise in
the KO (Fig. 5, A to G). Thus, depolarized mitochondria discharge
their Ca2+ content and fail as a Ca2+ buffer to serve as a source of the
enhanced delayed [Ca2+]c rise in the KO neurons and could confer
vulnerability to the glutamate-induced DCD.
Excitotoxic glutamate induces DCD via mitochondrial Ca 2+
overload and the ensuing PTP opening (39). A pharmacological
evidence for the involvement of PTP opening was that preincuba
tion with NIM811, a potent blocker of the PTP, delayed the occur
rence of glutamate-induced DCD (Fig. 5H). As NIM811 blocks PTP by
binding to cyclophilin, we compared the protein levels of cyclophilin
D in WT and KO neurons and found no difference (fig. S2D). We
Singh et al., Sci. Adv. 8, eabj4716 (2022)
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next tested the glutamate-induced neuronal cell death by measuring
plasma membrane permeabilization over time (Fig. 5, I and J). The rate
of glutamate-induced cell death was approximately twofold higher in the
KO neurons as compared with WT. We carried out similar experiments
with heterozygous MICU1+/− (HT) neurons having one functional
allele of MICU1 and found no major differences in glutamate-induced
DCD between WT and heterozygous neurons (fig. S4, B to H) and
neuronal viability (fig. S4, I to J). Immunoblot analysis for uniporter
complexes showed no difference between HT and WT neurons (fig. S4A),
suggesting that a single allele of MICU1 in HT is sufficient to produce
MICU1 protein comparably to that in WT. This result also explains
why HT neurons produced similar response to excitotoxic glutamate
as in WT. Thus, the complete loss of MICU1 makes primary cortical
neurons more vulnerable to [Ca2+]m overload and PTP opening,
culminating in progressive neuronal death.
To test whether the same pathway might apply to the neurons of
the adult nKO mice, we evoked [Ca2+]m overload in isolated cortical
mitochondria by applying a series of Ca2+ boluses. We found that
mitochondria from nKO mice tolerated fewer Ca2+ pulses before
the precipitous [Ca2+]c rise occurred (Fig. 5, K and L, and fig. S2E).
We postulated that it was mediated through PTP opening, and this
idea was validated pharmacologically by the protective effect of cy
closporin A (CsA), an inhibitor of the PTP (Fig. 5, K and L).
MICU1-deficent patient cells are sensitized to delayed Ca2+
dysregulation and cell death
Similar to the MICU1-KO neurons, human MICU1-deficient patient
fibroblasts (9) also have lower activation threshold for mitochondrial
6 of 13
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Fig. 4. Altered basal [Ca2+]m, and [Ca2+]c-[Ca2+]m coupling upon PFES in MICU1-KO neurons. (A) Mean traces for [Ca2+]c (left) and [Ca2+]m (right) rise in primary cortical
neurons upon 10 s of 20-Hz PFES (N = 24 WT and 20 KO). (B) Time when [Ca2+]m rise was at the half maxima upon PFES, calculated from the traces in panel A. (C) Basal
[Ca2+]m levels were measured in the neurons expressing mitochondrial targeted ratio metric sensor GEM-GECO; the bar graph represents the GEM-GECO-470/535 ratios
(N = 54 WT and 53 KO). (D) Mean [Ca2+]c traces and (E) maximum [Ca2+]c rise induced by FCCP (2 M) and oligomycin (10 M) in primary cortical neurons (N = 23 WT and
22 KO). P > 0.05; **P < 0.01; ***P < 0.001.
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Ca2+ uptake (fig. S5, A to C) (41), which was rescued by reintroduc
tion of MICU1-HA (fig. S5D). We tested here the vulnerability of
MICU1-patient fibroblasts to DCD-induced cell death. We exposed
the human fibroblasts to prolonged Ca2+ entry in combination with
H2O2 that synergizes with Ca2+ in PTP opening (Fig. 6A). We ob
served an initial [Ca2+]c peak followed by a plateau gradually turning
to a second [Ca2+]c increase with slow kinetics (Fig. 6A). MICU1-
deficient patient cells showed higher delayed [Ca 2+]c increases
(Fig. 6B). Cell viability was quantified by measuring the retention
time of the furaFF dye in the cytoplasm along the course of the ex
periment. MICU1-deficient fibroblasts had higher rate of cell death
compared with control cells (Fig. 6C). Reintroduction of the MICU1
gene gave protection against the secondary [Ca2+]c rise (Fig. 6,
D and E) and cell death (Fig. 6F) in the MICU1-deficient patient
fibroblasts, confirming loss of MICU1 as the cause of DCD suscepti
bility. Because PTP opening is central to the DCD and the ensuing cell
death, we assumed that PTP blocking by CsA would rescue patient
Singh et al., Sci. Adv. 8, eabj4716 (2022)

18 March 2022

fibroblasts from cell death. Overnight CsA (5 M) treatment resulted
in protection of patient fibroblast cells against the cell death caused
by Ca2+ overload (Fig. 6F). The studies of the patient fibroblasts
were also performed with the lymphoblasts of another MICU1-
deficient patient (15), and the results showed the same outcome
observed in the MICU1-deficient patient fibroblasts (fig. S5, E to G).
DISCUSSION

In this study, we showed that neuron-specific homozygous MICU1
deletion in mouse leads to altered neuronal Ca2+ homeostasis and
progressive motor and cognitive dysfunction likely in both males and
females. These phenotypes recapitulate those previously reported in
patient fibroblasts/lymphoblasts and the symptoms displayed by many
MICU1-deficient male and female patients (12–15, 62, 63). Heterozygous
micu1 neurons and nKO mice have no significant impairments, which
is consistent with literature on most individuals with heterozygous
7 of 13
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Fig. 5. Enhanced susceptibility to glutamate-induced delayed Ca2+ dysregulation and cell death in MICU1-KO neurons. (A) Individual (left) and mean (right) [Ca2+]c
traces measured in primary cortical neurons upon 5 M glutamate (Glu) stimulation by furaFF. (B) Baseline subtracted Glu-induced [Ca2+]c rise. (C) Additional [Ca2+]c rise
upon FCCP (2 M) and oligomycin (10 M) addition after Glu stimulation, measured as shown in (A) by subtracting [Ca2+]c of 8 min from that at 10 min. (D) Time to reach
the half-maximal [Ca2+]c rise. (E) m measured with TMRM simultaneously with [Ca2+]c [see (A)]. Individual (left) and mean (right) traces. (F) Glu-induced depolarization
relative to FCCP + oligomycin–induced depolarization. (G) m normalized to baseline at the median half-maximal time of the Glu-induced [Ca2+]c rise [see (D)]. (A to G)
16 WT, 33 KO runs with N = 104 WT, 257 KO neurons. (H) Rescue of Glu-induced maximum [Ca2+]c rise with NIM811 (100 M), uncoupler-induced residual mitochondrial
Ca2+ discharge, and time to reach half-maximal [Ca2+]c rise) in KO neurons. (I) Cultured primary neurons loaded with calcein-AM dye, before (0), and 90 and 240 min after
Glu stimulation; scale bar, 100 m. (J) Viability of neurons upon excitotoxic Glu stimulation (5 M) (N = 3 independent experiments). (K) Ca2+ retention capacity measured
on purified cortical mitochondria, mean traces showing the extra-mitochondrial calcium measured using furaFF after repetitive addition of 5 M CaCl2 boluses in the
presence or absence of cyclosporine A (5 M, CsA added at 0 s) (N = 3). (L) Mitochondrial Ca2+ retention capacity calculated as the number of calcium boluses at which
extramitochondrial calcium recover at least 50% from the peak. ns, not significant; P > 0.05; *P < 0.05; ***P < 0.001; ****P < 0.0001.
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MICU1 mutation (14, 15, 62). This is likely because lymphoblasts de
rived from humans with heterozygous MICU1 mutation (15), and
neurons derived from HT mice (fig. S4) showed no decrease in the
mtCU protein abundance, suggesting that one normal allele is suf
ficient to provide a normal amount of MICU1. Our findings that
the motor defects in the nKO mouse were significant and were
missing in the skeletal muscle-specific MICU1-KO mouse indicate
that the pathological changes due to neuron-specific loss of MICU1
are the main cause of the motor deficiency in patients. Moreover,
unaltered MICU1 protein abundance in SM mitochondria and nor
mal muscle fiber morphology of nKO animals suggest that demise
in motor function was not because SM alterations. On the basis of
the nKO mouse results, it is likely that loss of MICU1 postnatally is
not too late to induce neuronal pathology.
The altered structure of the dendritic spine is a hallmark of aging
and neurodegeneration associated with cognitive and motor im
pairments (64–66). More specifically, a decrease in spine density
[~20 to 30% (65, 67, 68)], length (68), and spine head diameter [~10
to 15% (67, 68)] are found in mouse models of various neurodegen
erative diseases with motor dysfunction like Parkinson’s disease,
Huntington’s disease, and spinal cord injury. Similar structural
changes are found in Alzheimer’s disease mouse models and are
believed to define the cognitive impairment (69, 70). Consistent
with these reports, we found a change in dendritic spine morpholo
gy of similar magnitude in the motor cortex of aged nKO animals
Singh et al., Sci. Adv. 8, eabj4716 (2022)
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(18 months), and more subtle alterations even in early age (3 months).
We also found motor neuron degeneration, a hallmark in motor neu
ron disease (68, 71, 72), in the anterior horn of the spinal cord of
nKO mice. Together, our results suggest that the loss of dendritic
spine morphology from the motor cortex and motor neuron degen
eration in the anterior horn of spinal cord might be plausible rea
sons for the behavioral abnormalities of nKO animals.
Dendritic alteration (9, 73) and neurodegeneration (6, 7, 74)
have been associated with altered mitochondrial Ca2+ homeostasis.
We found the following signs of dysregulation in MICU1 neurons:
(i) [Ca2+]m is elevated at rest, (ii) [Ca2+]m increases further from
[Ca2+]c elevations that are subthreshold in WT, (iii) mitochondria
are prone to Ca2+ overload and PTP opening, and (iv) synaptic
activity–related [Ca2+]c signaling is altered (suppressed response to
Bicu + 4AP). Moreover, we provided direct proof that altered
[Ca2+]m handling makes MICU1-KO neurons more vulnerable to
glutamate-induced DCD and cell death, which is similar to humans
in which MICU1-deficient patient-derived fibroblasts/lymphoblasts
show DCD and mortality upon sustained [Ca2+]c rise. These find
ings highlight the role of MICU1 in maintaining proper mitochon
drial Ca2+ handling in favor of cell survival.
MICU1-KO is associated with down-regulation of EMRE and
MICU3 proteins, and this raises the question whether the pheno
type that we observed in the various MICU1-KO models (KO, nKO,
and MICU1-deficient patient-derived fibroblasts/lymphoblasts)
8 of 13
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Fig. 6. Delayed Ca2+ dysregulation and cell death in MICU1-deficient patient fibroblasts and its prevention by MICU1 rescue. (A) Mean [Ca2+]c traces of store-
depleted human control and MICU1-deficient patient fibroblasts stimulated by the addition of H2O2 (1 mM) and Ca2+ (CaCl2 10 mM), (B) change in maximum [Ca2+]c, and
(C) cell viability (N = 8 pairs of runs). (D) [Ca2+]c traces for human MICU1-deficient patient fibroblasts rescued with MICU1, (E) maximum [Ca2+]c, and (F) H2O2 + Ca2+–induced
patient fibroblast cell death rescued with MICU1 and CsA (5 M overnight) (N = 10 nonrescued, 11 MICU1 rescued, and 9 CsA rescued runs). ns, not significant; P > 0.05;
*P < 0.05; **P < 0.01; ***P < 0.001.
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MATERIALS AND METHODS

Generation of the MICU1-KO/KO mice
All animals were used in accordance with the mandated standards
of humane care and were approved by the Thomas Jefferson Uni
versity Institutional Animal Care and Use Committee. To obtain
MICU1 floxed (MICU1F/F) and MICU1-KO (MICU1−/−) mice, the
Cre-loxP system was used to target exon 3 of the MICU1 gene for
removal on C57BL/6J background as described earlier (42).
Generation of the neuron-specific MICU1 knockdown mice
To obtain neuron-specific MICU1-KO mice MICU1-nKO, Eno2cre
mice (the Jackson Laboratory) were crossed with the MICU1F/F mice.
Genotypes were determined by polymerase chain reaction (PCR)
analysis of genomic DNA isolated from tail biopsies using the
following primers: loading control—CAGE NDEL, 5′-GGTGGAGT
C A A A G G G A G G A A C A G -3′ (forward) and 5′GCCCCATC
TATGATAATGTTAAGC-3′ (reverse); MICU1 deletion—KO,
5′-ATGAGCATGAAGTGATGACCCGAC-3′ (forward) and 5′-GC
CCCATCTATGATAATGTTAAGC-3′ (reverse); Cre expression—
Cre, 5′-CAGAACCTGAAGATGTTCGC-3′ (forward) and
5′-TACACCTCGGTGCTAACCAG-3′ (reverse). smKO animals
were bred as described earlier (41).
Tissue isolation and histological analysis
Male and female mice of different age groups were euthanized by
cervical dislocation.
Tibialis anterior muscle from 9-month-old animals were isolated,
fixed in 10% neutral buffered formalin, and then embedded in
Singh et al., Sci. Adv. 8, eabj4716 (2022)
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paraffin. Hematoxylin and eosin staining was performed at the trans
lational research/pathology shared resource at the Thomas Jefferson
University. Images were acquired using a Zeiss Axio Observer
microscope with DFC420 digital camera (Leica). Muscle fiber area,
perimeter, Feret, and minimum Feret were measured in ImageJ
[National Institutes Health (NIH)].
Brain and spinal cord were dissected from euthanized male mice,
then washed with 0.1 M phosphate-buffered saline (PBS), and then
fixed in ice-cold 4% paraformaldehyde for 48 hours and subsequently
cryopreserved in 30% sucrose for 48 hours. Coronal sections of
10 m were cut using cryotome, mounted on gelatin-coated glass
slides, and dried overnight at room temperature. Nissl (cresyl violet)
staining was performed as described earlier (76). For Golgi staining,
the brain tissue was processed following the manufacturer’s protocol
(FD Rapid GolgiStain Kit, no. PK401A).
For immunostaining, the sections were washed with 0.1 M PBS
(three times), permeabilized with 0.4% Triton X-100, blocked with
5% normal goat serum, and incubated with the primary antibody
overnight at 4°C (ChAT, ab178850, 1:250 and GFAP, ab7260, 1:1000).
The sections were washed twice with PBS and followed by incubation
with fluorescence-tagged (Alexa Fluor 488) secondary antibodies
(1:250) for 24 hours. Immunostained sections were washed twice
with PBS and mounted with Antifade, photographed using a Zeiss
LSM 880 confocal microscope, and analyzed in ImageJ (NIH).
Isolation of mitochondria
Mitochondria from cerebral cortex of male and female mice were
isolated using Percoll (Sigma-Aldrich, St. Louis, MO) density gradient
as described previously (77, 78).
Protein extracts and Western blotting
Protein lysates from tissues or mitochondria were prepared in ra
dioimmunoprecipitation assay (RIPA) buffer (Sigma-Aldrich) sup
plemented with protease inhibitors [leupetin, antipain, pepstatin, and
phenylmethylsulfonyl fluoride (PMSF); Sigma-Aldrich]. Equivalent
amounts of total protein (50 g) were separated electrophoretically
by SDS–polyacrylamide gel electrophoresis (10 or 12% TGX gels,
Bio-Rad) in reducing conditions, transferred to a nitrocellulose
membrane (Bio-Rad) then blocked in Odyssey blocking solution
(LI-COR) for 1 hour at room temperature, and probed overnight at
4°C using the following primary antibodies: MICU1 (Sigma-Aldrich,
HPA037480; 1:500), MICU2 (Abcam, ab101465; 1:500), MCU (Sigma-
Aldrich, HPA016480; 1:500), MICU3 (Sigma-Aldrich, HPA024048;
1:1000), EMRE (Santa Cruz Biotechnology, sc-86337; 1:200), anti-
CCDC109B/MCUB (Abcam, ab170715; 1:1000), NCLX (Santa Cruz,
sc161921; 1:500), cyclophilin D (Abcam, ab110324; 1:1000), and
Hsp70 (Thermo Fisher Scientific, MA3-028; 1:1000). Membranes were
scanned using an Odyssey scanner (LI-COR) after incubation with
fluorescent secondary antibodies. Quantification was performed
using ImageJ (NIH) (36).
RNA isolation and quantitative PCR
Total RNA were extracted from cells using the Animal Tissue RNA
Purification Kit (Norgen) according to the manufacturer’s instruc
tions. Quantification was done on the nanophotometer Pearl (Implen).
cDNA was synthesized using SuperScript III (Invitrogen) and used
for quantitative PCRs (qPCRs) using SYBR Green (Invitrogen) on
an ABI Prism 7000 sequence detection system (Life Technologies).
Data were analyzed using the comparative 2−Ct method. Ct of
9 of 13

Downloaded from https://www.science.org at Thomas Jefferson University on April 05, 2022

might have resulted from the decreased abundance of these proteins.
However, in contrast to MICU1 loss, EMRE loss is known to reduce/
block the mitochondrial Ca2+ uptake, and lowering EMRE expres
sion protects MICU1-KO mitochondria against Ca2+ overload and
ameliorates MICU1-KO phenotype in mice (26, 46). Thus, EMRE
down-regulation seems to be part of an adaptive action to decrease
mitochondrial Ca2+ uptake. Nevertheless, the compensation by
EMRE loss is insufficient to prevent Ca2+ overload. MICU3 was de
scribed to positively regulate mtCU function through the formation
of dimers with MICU1 and to interact with mtCU only as a MICU1MICU3 heterodimer (33). The MICU3 protein decrease in the
absence of MICU1 might occur because the monomeric MICU3
becomes unstable and gets degraded or because a feedback mecha
nism inhibits its expression either at the transcriptional or trans
lational level. Because MICU3 cannot bind to the mtCU in the
absence of MICU1, MICU3 is unlikely to have its own role in the
MICU1-KO phenotype.
Mitochondrial Ca2+ uptake is critical for glutamate-induced DCD
(75). Therefore, we predict that pharmacological targeting of the
mtCU could alleviate DCD and neuronal injury. Likewise, the pro
tective effect of PTP inhibitors in both neurons and patient fibro
blasts points to another potential therapeutic strategy. In summary,
our results identify a progressive chain of events starting from al
tered neuronal mitochondrial Ca2+ uptake and Ca2+ overload that
leads to abnormal dendritic spine barbarization and neuronal death
that culminates in the development of motor and cognitive disabili
ties seen in human MICU1 patients. These results are also expected
to stimulate studies of a possible role of MICU1 in determining the
pathophysiology in common neurological disorders.
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the gene of interest was normalized to that of -actin. Primers used are
listed as follows: MICU1, 5′-AACAGCAAGAAGCCTGACAC-3′
(forward) and 5′-CTCATTGGGCGTTATGGAG-3′ (reverse); MICU2,
5′-GGAGCGTAAAACACTGGTC-3′ (forward) and 5′-GTAAGCAAG
AAAAGATACTCGG-3′ (reverse); MICU3, 5′-GCCCAAATTTGCT
AAAACGTG-3′ (forward) and 5′-TCTAAAACCTGCATGGGGCT-3′
(reverse); EMRE, 5′-TCAGTCATCGTCACTCGC-3′ (forward)
and 5′-AAGCAGAGCAGCGAAGTTC-3′ (reverse); MCU, 5′-TACT
CACCAGATGGCGTTC-3′ (forward) and 5′-GTCCTCTAACCT
CTCCAC-3′ (reverse); -actin, 5′-CAACACCCCAGCCATG-3′
(forward) and 5′-GTCACGCACGATTTCCC-3′ (reverse).
Behavioral tests
Behavioral tests were performed on male and female mice in different
age groups.

Rotarod
Sensorimotor coordination and balance were assessed using Rotamex
4/5 device (Columbus Instruments, Columbus, OH). Animals were
tested for 3 days, three trials each day, on a rotating rod accelerating
gradually from 12 to 35 rpm in 3 min. Latencies for the mouse to fall
from the rod were recorded (48).
Pole test
Vertical pole task was done using a 55-cm-long and 0.8-cm-diameter
wooden pole. Animals were placed on the top part of the pole head
facing upward. Latencies to turn through the 180°, to descend once
turned, and to complete the task were measured for a maximum
time of 120 s. Failure to turn, falling, or slipping down backward
was scored with 120 s (80).
Barnes maze
Spatial learning and memory were tested on a brightly lit, exposed
circular (1.2 m in diameter) open platform surface with a small dark
recessed escape box located under 1 of the 18 evenly spaced holes
around the perimeter of the platform. The position of the escape
box relative to the other holes and the testing room remains fixed
during the whole study.
Animals were tested for four consecutive days, four trials each
day. Animals were placed under a start box in the center of the maze
for 30 s, then the box was removed, and the mouse was allowed to
explore freely to find the escape box for a maximum time of 150 s
(81). Animals were video-tracked, and parameters were analyzed in
ANY-maze (Stoelting Co., Wood Dale, IL).
Cortical neuronal culture
Primary embryonic neuron cultures were prepared as described
earlier (44, 82). Briefly, embryonic mice were removed on gesta
tional days 14 to 16, and the brains were removed. Cortical hemi
spheres were dissected, chopped, and incubated for 10 min in
Singh et al., Sci. Adv. 8, eabj4716 (2022)
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Human fibroblast culture
Human fibroblast cells (13) were created and gifted by R. Horvath
(Newcastle). Cells were grown in DMEM medium supplemented with
10% FBS (Gibco), penicillin (100 U/ml), streptomycin (100 g/ml),
and 2 mM glutamine (Gibco) and kept in 37°C and 5% CO2.
Human lymphoblast culture
Human lymphoblasts (15) were created and gifted by A. Roos
(Essen). Cells were cultured at 37°C in a 5% CO2 atmosphere. RPMI
1640 medium with l-glutamine (Gibco) with 20% FBS (Gibco), 1%
penicillin/streptomycin was used.
Transfection
Primary cortical neurons or human fibroblasts were transfected with
Lipofectamine 3000 (Invitrogen) according to the manufacturer’s
instructions using the following constructs: mtRCaMP, mtGCaMP6f,
mtGem-GECO1, MICU1-HA, and mito-Cepia. To rescue the human
MICU1-deficient patient fibroblasts with MICU1, the MICU1-HA
and the fluorescent, mitochondrial targeted mito-Cepia constructs
were cotransfected in a 1:1 ratio. Transfected cells were identified
under a fluorescence microscope.
Ca2+ imaging experiments
Primary cortical neurons or human fibroblasts were plated on 25-mm
glass coverslips. Fibroblast cells were transfected 48 hours before
imaging experiments, and primary neurons were transfected at day
7 after culture and imaged between 13 and 15 days after plating. For
measurements of [Ca2+]cyto, neurons were loaded with 2 M fura2/
acetoxymethyl ester (AM) (Invitrogen) or furaFF/AM (Invitrogen)
in Hanks’ balanced salt solution (HBSS; Gibco, 14025076) in the
presence of 0.003% Pluronic F-127 for 30 min at 37°C.
Fibroblasts were loaded with 2 M fura2/AM (Invitrogen) or
furaFF/AM (Invitrogen) in serum-free extracellular medium [ECM;
121 mM NaCl, 5 mM NaHCO3, 10 mM Na-Hepes, 4.7 mM KCl,
1.2 mM KH2PO4, 1.2 mM MgSO4, 2 mM CaCl2, and 10 mM glucose
(pH 7.4)] containing 2% bovine serum albumin (BSA) (Roche) in
the presence of 0.003% Pluronic F-127 and 100 M sulfinpyrazone
for 10 min at 37°C. For store-operated Ca2+ entry, fibroblast cells
were predepleted with 2 M thapsigargin (Enzo), and global [Ca2+]c
were raised by adding back 10 mM CaCl2 in the presence or absence
of 1 mM H2O2 in Ca2+-free ECM containing 0.25% BSA.
For [Ca2+]c and [Ca2+]m imaging, we used a ProEM1024 EMC
CD camera (Princeton Instruments) fitted to a Leica DMI6000B
inverted microscope with Lambda DG4 wavelength-switch xenon
light source (Sutter Instruments), operated by a custom software
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Grip test
Grip test was performed to analyze their limb strength. Animals
were allowed to grasp a 4-mm-diameter metal bar placed horizon
tally about 50-cm height from a soft bedding with their fore paw.
Latency of animal to fall from the bar was recorded for five trials
with 1 to 2 min of recovery period after each trial, and the scores
were averaged. Animals were removed from the bar when the crite
rion time of 60 s was reached (79).

Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich,
St. Louis, MO) containing 0.25% trypsin. The digestion reaction was
then stopped by adding DMEM supplemented with 10% fetal bo
vine serum (FBS) and spun for 2 min at 200g. The pellet was further
washed two times with DMEM with FBS. Supernatant was discard
ed, and the brains were triturated 10 to 14 times in neurobasal me
dium without supplement and spun down for 5 min at 200g. The pellet
was resuspended in neurobasal medium with B27 (Gibco, 17504-044)
and GlutaMAX (Thermo Fisher Scientific, 35050-061). After tritu
ration, cells were passed through a 75-m strainer and plated on
25-mm coverslips (Carolina Biological Supply Co., Burlington, NC)
coated with poly(l-lysine) (Sigma-Aldrich, P1524) and maintained
in a humidified incubator at 37°C in 5% CO2.
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(Spectralyzer). Fura2 fluorescence was recorded at 340- and 380-nm
excitation, and the mitochondrial matrix-targeted mtCEPIA and
GCaMP6f was excited at 485/15 nm, RCaMP at 545/20 nm, and
mtGEM-GECO at 405 nm using dual-band dichroic and emission
filter (Chroma, set 73100). The images were acquired from 200-ms
to 1.5-s interval. Traces for fluorescence intensities were obtained
by taking average from all cells in a field and were considered as one
measurement.
[Ca2+]m traces obtained from nonratiometric sensors were nor
malized to their baseline intensity obtained before stimulation. Basal
[Ca2+]m was measured by calculating the ratio of blue (470 nm) and
green (535 nm) emission of mtGEM-GECO. [Ca2+]c measurements
with fura2 in intact cells were calibrated in vitro as described (83).

Mitochondrial Ca2+ uptake study
Fluorometric measurements of mitochondrial Ca2+ clearance were
performed as previously described (20). Briefly, 300 g (for PTP
experiment) and 750 g (for uptake study) of isolated mouse brain
cortical mitochondrial protein were resuspended in 1.5 ml of intra
cellular medium [120 mM KCl, 10 mM NaCl, 1 mM KH2PO4, 20 mM
tris-Hepes (pH 7.2)] supplemented with proteases inhibitors (leu
petin, antipain, and pepstatin, 1 g/ml each), 2 mM Mg–adenosine
5′-triphosphate (ATP), and 2 M thapsigargin (Enzo) and main
tained in a stirred thermostated cuvette at 35°C. For PTP experi
ments, the intracellular medium was used without Mg-ATP. Assays
were performed in the presence of 20 M CGP-37157 (Enzo) and
1 mM malate/pyruvate using a DeltaRAM fluorimeter (Photon Tech
nology International). The extramitochondrial Ca2+ concentration
[Ca2+]c was measured by the ratiometric Ca2+ probe furaFF (1 M)
using 340- to 380-nm excitation and 500-nm emission. Calibration
of the furaFF signal was carried out at the end of each measurement,
adding 1 mM CaCl2, followed by 10 mM EGTA/tris (pH 8.5).
Measurement of m
Primary neurons were loaded with 6 nM TMRM in HBSS for 30 min.
Dye was excited at 545/20 nm, and, to avoid TMRM depletion while
imaging, the bath solution was incubated with 3 nM TMRM.
Viability test
Human fibroblast cells were loaded with furaFF/AM and treated
with thapsigargin (2 M) in Ca2+-free ECM. Ca2+ (10 mM) and
H2O2 (1 mM) were added to induce delayed calcium dysregulation.
furaFF signal was recorded for 50 min at 10-s time interval. For the
rescue experiments, cells were cotransfected with MICU1-HA and
mtGCaMP6f. To test the dependence of the phenotype on PTP
opening, fibroblast cells were incubated with 5 M CsA overnight.
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Statistical analysis
Data are expressed as means ± SEM unless stated otherwise. Box
plots are shown as follows: center line, median; box limits, upper
and lower quartiles; whiskers, 1.5× interquartile range; and points,
outliers. Experiments were performed at least three times in dupli
cates or more. When comparing two groups, statistical analysis was
performed using the unpaired, two-tailed Student’s t test [Figs. 1
(B to D, F, and G), 2 (G {3 months} and I), 3 (A to C and H), 4 (B
and E), 5 (B to D and F to H), and 6E; figs. S1 (B {grip test and rotarod,
pole test at 3 months} to D, S2 (A to D), and S4A] or Mann-Whitney
rank sum test when normality or equal variance test failed [Figs. 1H,
2 (A to C and G {18 months}), 3 (E and K), 5H, and 6B; figs. S1 (B
{pole test at 9 months} and E), S3 (J to M), S4 (C to E, G, and H), and
S5 (A to C and F)]. In the above cases, data are expressed as means ±
SD. For multiple comparisons, we used one-way analysis of variance
(ANOVA) (Figs. 5L and 6F). To compare two groups with repeated
measurements, two-way ANOVA was used (Holm-Sidak method)
(Figs. 1E and 2F). Survival curves were analyzed with Kaplan-Meier
survival analysis with log-rank (Figs. 5J and 6C, and figs. S4J and S5G).
Statistical significance was labeled as follows: not significant (ns),
P > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. All
statistical tests were performed using Systat SigmaPlot 12.5.
SUPPLEMENTARY MATERIALS

Supplementary material for this article is available at https://science.org/doi/10.1126/
sciadv.abj4716
View/request a protocol for this paper from Bio-protocol.
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Pulse field electric stimulation
Primary cortical neurons cultured on glass coverslip were placed on
the O-ring–based perfusion chamber with stimulator (RC-49MFSH)
and filled with 150 l of imaging buffer (HBSS added with 50 M
d,l-2-amino-5-phosphonovaleric acid and 10 M GYKI-52466HCl; Sigma-Aldrich). During field stimulation, neurons were con
tinuously perfused with the imaging buffer using gravity-based
custom-made perfusion system. The action potentials were evoked
at 40 V/cm field achieved by passing 150 pulses (2-ms pulse, 20 Hz)
of current using platinum field stimulation electrode (RC-49MFSH).
The [Ca2+]c and [Ca2+]m rise evoked by electric field stimulation was
imaged as described above in calcium imaging panel.

Primary cortical neurons were loaded with 2 M of calcein-AM
(Invitrogen) in the presence of 0.003% Pluronic F-127 in HBSS me
dium. Neurons were stimulated with 5 M glutamate and imaged
for 4 hours with 30-min intervals. The number of cells were counted
in each frame.
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